The esteemed ESMO Award was established in 1985 to recognise an ESMO member who has made an outstanding contribution to the development of medical oncology by promoting it as a speciality within the European and/or international community
2018 – Jean-Charles Soria, USA
The ESMO Award will be presented to Jean-Charles Soria during the Opening Session of the ESMO 2018 Congress in Munich on Friday, 19 October 2018.
Soria is a Full Professor of Medicine and Medical Oncology, University of Paris-Sud since 2006. From 2013 to 2017 he was Head of the Drug Development Department (DITEP), Gustave Roussy, Villejuif, France and Adjunct Professor, MD Anderson Cancer Centre, Houston, US. He is currently Senior Vice President and Head of the Oncology Innovative Medicines Unit at MedImmune, US.
His relentless interest in research has been focused mainly on early clinical development, pharmacodynamic biomarkers, lung cancer management and personalised medicine. Soria has been involved in translational research related to precision medicine and tumour progression, notably in lung cancer, and has led multiple precision medicine trials. Soria was Editor-in-Chief of ESMO’s flagship scientific journal Annals of Oncology from 2014 to 2017. Under his leadership the journal reached an impact factor of 13.926
This is truly an immense honour, a very clear recognition by the international community of the quality of my clinical and translational work. Receiving this award while being only 47 years old is really very special. I have been an ESMO member since 1996 and I have always been deeply attached to the Society. To receive such a visible award from it is an enormous sign of encouragement for me.
Evandro de Azambuja, Chair of the ESMO Fellowship and Award Committee, said: “Soria has been a true leader to the medical oncology community. He has been an inspiration for the young generation with his great lectures and as Editor-in-Chief of Annals of Oncology ensured that ESMO’s journal was ‘among the best oncology journals’.”
